Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03072381 · ClinicalTrials.gov registry record · Phase 2
PEAK Platelet Rich Plasma Injection Treatment for Chronic Lateral Epicondylosis
A Phase 2 study of Chronic Lateral Epicondylosis, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03072381 is a Phase 2 study of Chronic Lateral Epicondylosis that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03072381, a Phase 2 study of Chronic Lateral Epicondylosis, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed project will be the first to assess pain- and function-dependent, elbow-specific quality of life and in-vivo mechanical properties of common extensor tendons post-treatment with PRP in a Level 1, RCT with subject and assessor blinding. The valuable data gained will significantly add to the knowledge base of treatment effects of PRP for a chronic tendinopathy. Positive findings of PRP compared to control (corticosteroid injection) would suggest future larger scale studies to help establish an optimal protocol for the nonsurgical management of CLE. Correlating US and shear wave acoustoelastography imaging assessments with validated clinical outcomes will provide a powerful tool for future outcomes analyses using a non-invasive imaging modality to monitor tissue healing both morphologically as well as biomechanically, and may even be used to evaluate injury risk.
Conditions Studied
Interventions
- BIOLOGICAL Platelet Rich Plasma - Group 1
- DRUG Corticosteroid Control - Group 2
Study Locations (1)
Wisconsin
- Wisconsin Institute of Medical Research (WIMR) - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-01 |
| Est. Completion | 2020-10-28 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03072381
The ClinicalTrials.gov registry entry for NCT03072381 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Lateral Epicondylosis appearing as the primary indexed condition, and to 2 interventions - of which Platelet Rich Plasma - Group 1 is the first listed.
NCT03072381 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT03072381 about?
NCT03072381 is a clinical study titled "PEAK Platelet Rich Plasma Injection Treatment for Chronic Lateral Epicondylosis". The proposed project will be the first to assess pain- and function-dependent, elbow-specific quality of life and in-vivo mechanical properties of common extensor tendons post-treatment with PRP in a Level 1, RCT with subject and assessor blinding. The valuable data gained will significantly add to ...
What is the current status of trial NCT03072381?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2017-01. Estimated completion is 2020-10-28.
What conditions does trial NCT03072381 study?
This clinical trial studies the following conditions: Chronic Lateral Epicondylosis.
What interventions are being tested in trial NCT03072381?
The interventions under investigation include: Platelet Rich Plasma - Group 1 (BIOLOGICAL), Corticosteroid Control - Group 2 (DRUG).
Who is sponsoring clinical trial NCT03072381?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03072381 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.